Li Hung-Yuan, Lin Mao-Shin, Wei Jung-Nan, Hung Chi Sheng, Chiang Fu-Tien, Lin Cheng-Hsin, Hsu Hsiu-Ching, Su Chien-Yin, Wu Mei-Yu, Smith David J, Vainio Jani, Chen Ming-Fong, Chuang Lee-Ming
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Clin Chim Acta. 2009 May;403(1-2):97-101. doi: 10.1016/j.cca.2009.01.027. Epub 2009 Feb 4.
We investigated if serum vascular adhesion protein-1 (SSAO/VAP-1) changed acutely following oral glucose loading and whether such changes are correlated with surrogate markers of atherosclerosis.
A total of 115 non-diabetics subjects were enrolled for an oral glucose tolerance test (OGTT). Carotid intima-medial thickness (IMT) was measured by ultrasonography. Serum SSAO/VAP-1 was analyzed by time-resolved immunofluorometric assay. Serum thiobarbituric acid reactive substances (TBARS) and advanced glycated end products (AGEs) were measured by fluorometric assays.
Serum SSAO/VAP-1 increased significantly at 30 min after oral glucose loading and lasted to 2 h (p=0.0005 and p<0.0001, for 30 min and 2 h respectively). The area under curve of serum SSAO/VAP-1 during OGTT (AUC-VAP-1) correlated significantly with carotid IMT, independent of age, gender, low-density lipoprotein cholesterol, systolic blood pressure, hemoglobin A1c, serum TBARS, AGEs, and high-sensitivity C-reactive protein. Subjects with a positive AUC-VAP-1 had significantly higher serum TBARS and AGEs than subjects with a negative AUC-VAP-1 adjusted for age and gender.
Serum SSAO/VAP-1 changed acutely following oral glucose loading in non-diabetic subjects. Change of serum SSAO/VAP-1 correlated independently to serum TBARS, AGEs, and carotid IMT. Our findings suggest that acute change of serum SSAO/VAP-1 is a novel marker for hyperglycemia-induced atherosclerosis.
我们研究了口服葡萄糖负荷后血清血管粘附蛋白-1(SSAO/VAP-1)是否会急性变化,以及这种变化是否与动脉粥样硬化的替代标志物相关。
共纳入115名非糖尿病受试者进行口服葡萄糖耐量试验(OGTT)。通过超声测量颈动脉内膜中层厚度(IMT)。采用时间分辨免疫荧光分析法分析血清SSAO/VAP-1。通过荧光分析法测量血清硫代巴比妥酸反应性物质(TBARS)和晚期糖基化终产物(AGEs)。
口服葡萄糖负荷后30分钟血清SSAO/VAP-1显著升高,并持续至2小时(30分钟时p = 0.0005,2小时时p < 0.0001)。OGTT期间血清SSAO/VAP-1的曲线下面积(AUC-VAP-1)与颈动脉IMT显著相关,独立于年龄、性别、低密度脂蛋白胆固醇、收缩压、糖化血红蛋白A1c、血清TBARS、AGEs和高敏C反应蛋白。在根据年龄和性别进行调整后,AUC-VAP-1为阳性的受试者血清TBARS和AGEs显著高于AUC-VAP-1为阴性的受试者。
非糖尿病受试者口服葡萄糖负荷后血清SSAO/VAP-1会急性变化。血清SSAO/VAP-1的变化与血清TBARS、AGEs和颈动脉IMT独立相关。我们的研究结果表明,血清SSAO/VAP-1的急性变化是高血糖诱导动脉粥样硬化的一种新型标志物。